Skip to main content
. 2011 Aug;22(8):1453–1461. doi: 10.1681/ASN.2010080878

Figure 4.

Figure 4.

Protamine sulfate activates signaling through the calcineurin pathway. (A) Western blots show treatment with 600 μg/ml PS reduces the amount of full-length (110 kD) Synpo present in glomerular lysates. Pretreatment with 10 μM E64 prevents this reduction in full-length Synpo. (B and C) Pretreatment with 24 μg/ml FK506 (B) or 50 μg/ml cyclosporine A (C) reduces PS-mediated glomerular injury. (D) Treatment with 10 μM CatL inhibitor E64 partially blocks albumin release upon PS treatment.